Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor

BACKGROUND: Premenopausal women with high-risk hormone receptor (HR)-positive breast cancer often receive ovarian function suppression (OFS) with aromatase inhibitor therapy; however, abrupt menopause induction, together with further decrements in estrogen exposure through aromatase inhibition, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Jennifer H, D’Agostino, Ralph B, Ansley, Katherine, Douglas, Emily, Melin, Susan, Sorscher, Steven, Vasu, Sujethra, Park, Sung, Kotak, Anuj, Romitti, Paul A, O’Connell, Nathanial S, Hundley, William G, Thomas, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406435/
https://www.ncbi.nlm.nih.gov/pubmed/34476341
http://dx.doi.org/10.1093/jncics/pkab071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406435/
https://www.ncbi.nlm.nih.gov/pubmed/34476341
http://dx.doi.org/10.1093/jncics/pkab071

Ejemplares similares